Artificial Cells Nanomedicine and Biotechnology · 2019 · 15 citations · 23 references
PharmacyHematologyPharmaceuticsBiocompatibilityDrug DeliveryNanoparticle Drug DeliveryNanoparticle CharacterizationNanoparticle FormulationsBlood CompatibilityHemocompatibilityHemocompatible MaterialsHemolysis AssaysMembrane Surface ChargePlatelet Activation AssaysProtein Formulation
Blood compatibility is a key requirement to fulfil for intravenous administration of drug and oxygen carrier system. Recently, we published the fabrication of oxidised-dextran (Odex)-crosslinked protein particles by one-pot formulation. In the current study we investigate the haemocompatibility of these Odex - particles including albumin particles (Odex-APs) and haemoglobin particles (Odex-HbMPs). Odex-APs and Odex-HbMPs have a submicron size ranged 800-1000 nm with peanut-like shape and a negative surface charge. In vitro haemocompatibility assays included haemolysis test, indirect phagocytosis test and platelet activation test in human blood. Odex-APs and Odex-HbMPs did not provoke any undesirable effects on the blood cells. Firstly, the ratio of haemolysis after contacted with Odex-crosslinked protein particles were less than 5% and therefore the particles may be considered non-haemolytic. Secondly, the incubation of leukocyte with Odex-APs/HbMPs did not influence the phagocytosis of leukocyte. We conclude that our particles are not recognized by monocytes or granulocytes. Finally, exposure of Odex-APs/HbMPs to platelets did not cause an activation of platelets. Additionally, Odex-HbMP/AP did not enhance or attenuate agonist-induced platelet activation. We conclude that Odex-crosslinked protein particles exhibit a very good haemocompatibility and represent highly promising carriers for drugs or oxygen.
23
Martin Lundqvist, Johannes Stigler, Giuliano Elia et al. · Proceedings of the National Academy of Sciences · 2008 · 3K citations · Full text
Surface Charge Controls the Suborgan Biodistributions of Gold Nanoparticles
S. Gokhan Elci, Ying Jiang, Bo Yan et al. · ACS Nano · 2016 · 238 citations
The role of nanoparticle size in hemocompatibility
Andrea B. R. Mayer, Maria Vadon, Beate Rinner et al. · Toxicology · 2009 · 206 citations